INSIGHTS ON CELL & GENE CLINICAL TRIALS
-
Manufacturing CAR-T In Vivo
Manufacturing chimeric antigen receptor (CAR) T-cell therapies is a costly and complicated process. Interius BioTherapeutics is on a mission to reduce this complexity and get these therapies to patients faster — by manufacturing CAR cells in patients' bodies.
-
Spotlight On India: Regulatory Enhancements, Modernization, And Robust Data Collection
Explore India's adoption of global best practices, 24/7 work cycles, and audit readiness to ensure high standards of Good Clinical Practice, attract more trials, and provide robust data to stakeholders.
-
Improving Patient Health And Safety
Engage an experienced CMC program management consultant to collaboratively develop and maintain a robust product development plan (PDP) with your team lead, cross-functional members, and vendors.
-
Rocket Pharma's Modality-Agnostic Approach To Rare Disease
Rocket Pharmaceuticals’ president, COO, and head of R&D, Dr. Kinnari Patel, discusses the company’s modality-agnostic approach to treating rare diseases.
-
Extended GCP Training Is A "Must" For Cell And Gene Therapy Clinical Trials
Cell and gene therapies (CGTs) carry specific challenges and risks, and so all parties need enhanced training to ensure patient safety, data quality, and Good Clinical Practice (GCP) and regulatory compliance.
-
Why Leading Cancer Research Centers Trust OpenClinica For Oncology Trials
See eight key reasons why leading cancer research centers rely on OpenClinica to navigate the intricacies of oncology trials and advance the field of cancer research.
-
Making CGT More Accessible In The Treatment Of Solid Tumors
Examine the evolving landscape of cell and gene therapies, with a focus on expanding access, especially for treating solid tumors outside traditional academic settings.
-
How We Can Bring Gene Therapies To Bear On Diseases Of Aging
Explore the evolving landscape of clinical trials focused on Alzheimer’s and Dementia, underscoring challenges and opportunities in developing precise treatments for diseases associated with aging.
-
How To Build A Hybrid Visit Strategy That Delivers High-Quality Results
In-home clinical trial visits yield major benefits for patients, including increased access and convenience. As a result, hybrid trials are helping developers increase enrollment, engagement, and retention.
-
Strategies For A More Secure Outsourcing Bottom Line
A panel of experts from across the pharmaceutical/biopharmaceutical industry recently shared their experiences in mitigating financial risk before partnering with a contract research organization (CRO).